Changes of Th1/Th2 Cytokines Levels in Serum in Patients with Chronic Hepatitis B Before and after Treatment of Thymosin

LIU Yuan-yuan,MA Zhen-hua,PIAO Rong-li,NIU Jun-qi
DOI: https://doi.org/10.13481/j.1671-587x.2010.04.026
2009-01-01
Abstract:Objective To investigate the changes of Th1/Th2 cytokines levels in serum in patients with chronic hepatitis B patients befroe and after treatment of thymosin,and clarify the relationship with state of illness,curative effect and virological response.Methods 19 patients with chronic active hepatitis B were chosen as treatment group,10 cases as normal control group.The patients in treatment group were treated with injection of thymosin α 1 mL,in the pre-treatment,13 and 21 weeks after treatment the cytokine levels,HBV DNA,and biochemical indicators of liver function were detected by flow cytomertry on Tuesday,Friday every week;in normal control group the serum IL-2,IFN,TNF,IL-4,IL-6,IL-10 indicators were determined and the relationship between cytokine levels and biochemical responses and virological response was analyzed.Results After thymosin treatment,the cytokine levels secreted by Th cells were increased compared with pre-treatment (P0.05),the levels of Th1 cytokines (IL-2,IFN,TNF) in reponse group were higher than those in non-response group,the levels of Th2 cytokines (IL-4,IL-6,IL-10) in non-response group were higher than those in response group (P 0.05).According to biochemical response analysis,the cytokine levels in patients could reflect the curative effect,the cytokine levels in response group were lower than those in partial response group,the cytokine levels in part response group were lower than those in non-response group,the cytokine levels in response group were lower than those in non-response group,the increase of cytokine levels had negative correlation with curative effect of virological response (P0.05).Conclusion The changes of the levels of serum Thl/Th2 cytokines in patients with chronic hepatitis B after treatment of thymosin may contribute to the removal of HBVDNA in body.
What problem does this paper attempt to address?